STRM.BIO: Funding, Investors & Team (Sep 2026)
STRM.BIO is a biotech firm that utilizes extracellular vesicles as a means of delivering gene therapy in a more effective, secure, and feasible manner. Their objective is to fully realize the potential of gene therapy by employing extracellular vesicles to directly administer treatment to patients. These vesicles naturally transport nucleic acids and proteins and possess inherent targeting abilities, while also being easily produced on a commercial scale and causing minimal immune reactions.
STRM.BIO has raised $8.0M across 2 funding rounds on record, the most recent a Seed of $8.0M announced in Jan 2026.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
STRM.BIO Company Profile and Key Stats
Latest funding round on record: Jan 2026.
STRM.BIO Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
STRM.BIO announced an undisclosed round in Oct 2023; the amount was not disclosed.
2.3 years later, a Seed of $8.0M was announced in Jan 2026.
STRM.BIO Founders and Leadership Team
No contact details are on record for this team yet.
STRM.BIO Funding Compared to Other Biotechnology Startups
STRM.BIO's latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like STRM.BIO in Biotechnology and Cambridge
Companies Similar to STRM.BIO
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
STRM.BIO Funding FAQs
What does STRM.BIO do?
STRM.BIO is a biotech firm that utilizes extracellular vesicles as a means of delivering gene therapy in a more effective, secure, and feasible manner. Their objective is to fully realize the potential of gene therapy by employing extracellular vesicles to directly administer treatment to patients. These vesicles naturally transport nucleic acids and proteins and possess inherent targeting abilities, while also being easily produced on a commercial scale and causing minimal immune reactions.
How much funding has STRM.BIO raised?
STRM.BIO has raised $8.0M across 2 rounds on record. The most recent is a Seed of $8.0M announced in Jan 2026.
When did STRM.BIO last raise funding?
STRM.BIO's most recent funding round on record is a Seed of $8.0M, announced in Jan 2026.
Who founded STRM.BIO?
FundedIQ lists David Raiser (Founder), Jonathan Thon (Founder) at STRM.BIO.
Where is STRM.BIO headquartered?
STRM.BIO is based in Cambridge, Massachusetts, United States.
How many employees does STRM.BIO have?
STRM.BIO is in the 11-50 employee band.
How does STRM.BIO's funding compare to other Biotechnology startups?
STRM.BIO's latest round of $8.0M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's STRM.BIO Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for STRM.BIO is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.